BCRP was initially discovered in a multi-drug resistant breast cancer cell line that exhibited reduction in accumulation of chemotherapeutic drugs, even in the absence of P-gp and MRPs (Doyle et al., 1998). Here, ABCG2 is linked to breast cancer.